Deal Makers Close 2013 With String Of Big Pharma Plays

Law360, New York (December 20, 2013, 3:32 PM EST) -- Private equity and strategic buyers alike have zeroed in on the pharmaceutical industry over the past week, capping off a busy fourth quarter with a string of big-ticket deals that formed specialized powerhouses, broke up joint ventures and provided healthy exits.

As showcased in the last-minute flurry of more than a half-dozen deals, the life sciences sector has kept deal makers busy over the past several months. Though tech and telecom deals outshined virtually all others in 2013, drug companies and their investors have carved out...
To view the full article, register now.